Mylan Failed To Prove Identical Ingredients: Abbott Suit
Generic drug maker Mylan Pharmaceuticals Inc. failed to show the active ingredients in its version of epilepsy drug Depakote are identical to Abbott Laboratories' original version as required by U.S. Code,...To view the full article, register now.
Already a subscriber? Click here to view full article